MOB2: A Protein with Potential Drug Targeting and Biomarker Properties

Target Name: MOB2

NCBI ID: G81532

MOB2

MOB2: A Protein with Potential Drug Targeting and Biomarker Properties

MOB2 (MOB2 variant 1) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the MOB2 family of proteins, which are known for their role in cell signaling and division.

MOB2 has been identified as a potential drug target or biomarker due to its unique structure and its involvement in several important cellular processes.

One of the key functions of MOB2 is its role in the regulation of cell division. MOB2 has been shown to play a key role in the formation of mitotic spindles, which are the structures that allow a cell to properly divide into two daughter cells during cell division.

MOB2 has also been shown to be involved in the regulation of cell growth and the control of cell size. It has been shown to play a role in the production of new blood vessels, which is important for the growth and development of tissues.

In addition to its role in cell signaling and division, MOB2 is also involved in the regulation of inflammation. It has been shown to play a key role in the production of inflammatory cytokines, which are important for the immune response.

MOB2 has also been shown to be involved in the regulation of pain perception and neurotransmitter release. It has been shown to play a role in the production of pain-related neurotransmitters, such as serotonin and dopamine.

Despite its involvement in several important cellular processes, MOB2 is not well understood, and much research is needed to fully understand its role in the body.

One way to study MOB2 is through the use of techniques such as RNA interference, which allows researchers to knock down the expression of MOB2 and observe the effects on cellular processes.

Another way to study MOB2 is through the use of live cell imaging techniques, such as super-resolution microscopy. This allows researchers to visualize the structure of MOB2 and its interacting partners in real-time, which is important for understanding how MOB2 functions in the body.

In addition to these techniques, researchers have also used other methods to study MOB2, such as biochemical assays and cell-based assays. These methods provide valuable information about the behavior of MOB2 in the body.

While much research is still needed to fully understand the role of MOB2 in the body, the potential benefits of targeting MOB2 with drugs or other therapeutic agents are significant. MOB2 has been shown to play a key role in several important cellular processes, and its involvement in these processes makes it an attractive target for drug development.

In conclusion, MOB2 is a protein that has been identified as a potential drug target or biomarker due to its unique structure and its involvement in several important cellular processes. Further research is needed to fully understand its role in the body and to develop effective treatments based on its properties.

Protein Name: MOB Kinase Activator 2

Functions: Stimulates the autophosphorylation and kinase activity of STK38 and STK38L

The "MOB2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MOB2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets